THROMBOCYTOPENIA PURPURA

Clinical trials for THROMBOCYTOPENIA PURPURA explained in plain language.

Never miss a new study

Get alerted when new THROMBOCYTOPENIA PURPURA trials appear

Sign up with your email to follow new studies for THROMBOCYTOPENIA PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Head-to-Head trial tests best Second-Line treatment for low platelet disorder

Disease control Not yet recruiting

This study aims to find out which of two common second-line treatments works better for adults with immune thrombocytopenia (ITP), a condition that causes low platelet counts and bleeding risk. About 220 participants will be randomly assigned to receive either a daily pill (avatr…

Matched conditions: THROMBOCYTOPENIA PURPURA

Phase: PHASE3 • Sponsor: Ostfold Hospital Trust • Aim: Disease control

Last updated Feb 24, 2026 14:06 UTC

THROMBOCYTOPENIA PURPURA

Get alerted when new THROMBOCYTOPENIA PURPURA trials appear

Head-to-Head trial tests best Second-Line treatment for low platelet disorder